Literature DB >> 16565858

Radiofrequency induced thermotherapy: an alternative palliative treatment modality in head and neck cancer.

Tommi Liukko1, Antti A Mäkitie, Antti Markkola, Jukka Ylikoski, Leif Bäck.   

Abstract

Bipolar radiofrequency induced thermotherapy (RFITT) is a minimally invasive electrosurgical technique characterized by a precise controllable effect in the tissue. It has demonstrable efficacy, safety and reproducibility in the management of solid malignancies. Our aim was to assess the morbidity and efficacy of RFITT as a palliative treatment of head and neck cancer. Prospective, non-randomized case series and analysis. After evaluation by the multidisciplinary Head and Neck Tumour Board at Helsinki University Central Hospital, Finland, 12 consecutive patients with a head and neck cancer without curative treatment possibilities were enrolled into the study. Five patients had pharyngeal carcinomas, one had an unknown primary tumour growing through the skin on the neck, two had a recurrent malignant melanoma originating from the maxillary sinuses, one had a carcinoma of the tongue, two had laryngeal carcinomas, and one had a recurrent adenoid cystic carcinoma of the parotid gland. RFITT was performed with a CelonLabPrecision generator using appropriate electrodes. The treatment was administered under local or general anaesthesia. The subjective morbidity of the treatment was evaluated. The response to the treatment was assessed clinically and with radiological imaging when feasible. All but two of the patients received palliation to their disease. RFITT induced clinically a partial response in ten patients, and there were radiological detectable changes. There were no treatment related complications, and the patients tolerated the treatment well. RFITT in head and neck cancer patients is easy to perform, well tolerated, and induces reduction in the tumour mass. Continuous evaluation of RFITT treatment modality is warranted in selected palliative care patients.

Entities:  

Mesh:

Year:  2006        PMID: 16565858     DOI: 10.1007/s00405-005-0006-6

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  11 in total

1.  Radiofrequency ablation used to treat select renal and adrenal tumors.

Authors:  J Zuboy
Journal:  Curr Treat Options Oncol       Date:  2000-06

Review 2.  Radiofrequency ablation of unresectable primary liver cancer.

Authors:  Jerome Seidenfeld; Allan Korn; Naomi Aronson
Journal:  J Am Coll Surg       Date:  2002-06       Impact factor: 6.113

3.  Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients.

Authors:  L Solbiati; T Livraghi; S N Goldberg; T Ierace; F Meloni; M Dellanoce; L Cova; E F Halpern; G S Gazelle
Journal:  Radiology       Date:  2001-10       Impact factor: 11.105

4.  Radiofrequency ablation of breast cancer: first report of an emerging technology.

Authors:  S S Jeffrey; R L Birdwell; D M Ikeda; B L Daniel; K W Nowels; F M Dirbas; S M Griffey
Journal:  Arch Surg       Date:  1999-10

5.  Radiofrequency thermal ablation sharply increases intratumoral liposomal doxorubicin accumulation and tumor coagulation.

Authors:  Muneeb Ahmed; Wayne E Monsky; Geoffrey Girnun; Anatoly Lukyanov; Giuseppe D'Ippolito; Jonathan B Kruskal; Keith E Stuart; Vladimir P Torchilin; S Nahum Goldberg
Journal:  Cancer Res       Date:  2003-10-01       Impact factor: 12.701

Review 6.  Radiofrequency ablation of bony metastatic disease.

Authors:  A F Posteraro; D E Dupuy; W W Mayo-Smith
Journal:  Clin Radiol       Date:  2004-09       Impact factor: 2.350

7.  Techniques for radiofrequency ablation of head and neck tumors.

Authors:  Randall P Owen; Carl E Silver; Thanjavur S Ravikumar; Allan Brook; Jacqueline Bello; Dwayne Breining
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2004-01

8.  Recurrent advanced (T3 or T4) head and neck squamous cell carcinoma: is salvage possible?

Authors:  Lyon L Gleich; John Ryzenman; Jack L Gluckman; Keith M Wilson; William L Barrett; Kevin P Redmond
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2004-01

9.  A comparative experimental study of the in-vitro efficiency of hypertonic saline-enhanced hepatic bipolar and monopolar radiofrequency ablation.

Authors:  Jeong Min Lee; Joon Koo Han; Se Hyung Kim; Kyu Li Sohn; Kyoung Ho Lee; Su Kyung Ah; Byung Ihn Choi
Journal:  Korean J Radiol       Date:  2003 Jul-Sep       Impact factor: 3.500

10.  Single group study to evaluate the feasibility and complications of radiofrequency ablation and usefulness of post treatment position emission tomography in lung tumours.

Authors:  Shijun Kang; Rongcheng Luo; Wangjun Liao; Hubing Wu; Xuelin Zhang; Yuru Meng
Journal:  World J Surg Oncol       Date:  2004-09-06       Impact factor: 2.754

View more
  4 in total

1.  [Radiofrequency ablation as a palliative therapy option in ENT tumors: in vivo and in vitro testing].

Authors:  S Bucher; J Hornung; V Bonkowsky; H Iro; J Zenk
Journal:  HNO       Date:  2010-04       Impact factor: 1.284

2.  Radiofrequency ablation in advanced head and neck cancer.

Authors:  Randall P Owen; Jane S Lee; Carl E Silver; Leif Bäck; Jonathan J Beitler; Alessandra Rinaldo; Bert W O'Malley; Missak Haigentz; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-09-24       Impact factor: 2.503

3.  When is radiofrequency ablation not indicated in head and neck squamous cell carcinoma management?

Authors:  Leif J J Bäck; Antti A Mäkitie; Bert W O'Malley; Randall P Owen; Alessandra Rinaldo; Carl E Silver; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-06-01       Impact factor: 2.503

4.  Radiofrequency ablation vs. microwave ablation for patients with benign thyroid nodules: a propensity score matching study.

Authors:  Wen-Wen Yue; Shu-Rong Wang; Feng Lu; Li-Ping Sun; Le-Hang Guo; Yong-Lin Zhang; Xiao-Long Li; Hui-Xiong Xu
Journal:  Endocrine       Date:  2016-11-30       Impact factor: 3.633

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.